Drawing for RELEASE

USPTO serial 97188349

RELEASE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
BECKER, MARY ELIZABETH
Law office
TMEG LAW OFFICE 103 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with RELEASE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Randy R. Micheletti

Randy R. Micheletti INCUBATE IPP.O. box 3327Glen Ellyn, IL 60138UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
010Medical devices for treating sleep disorders; Medical devices for use in treating or diagnosing mental disorders resulting from suppression of emotions, memories, and thoughts; Medical devices for use in treating or diagnosing personality disorders; Medical devices for use in treating or diagnosing mental disorders, namely, anorexia, bulimia, and other eating disorders; Medical devices for use in treating or diagnosing mental disorders, namely, bipolar disorder, anxiety, depression, schizophrenia, and posttraumatic stress disorder; Medical devices for use in treating or diagnosing mental disorders resulting from addiction; Medical devices for use in treating or diagnosing neurological conditions; Medical devices for use in treating or diagnosing mental disorders treatable with psychotherapy, namely, depression, personality disorders, addictions, anxiety, schizophrenia, bipolar disorder, eating disorders, and posttraumatic stress disorder; Medical devices for use in treating or diagnosing anger issues; Medical devices for use in treating or diagnosing suicidal impulses, and suicidal ideations; Medical devices for use in treating or diagnosing homicidal ideations, homicidal impulses, and homicidal acts; Medical devices for use in treating or diagnosing mental conditions resulting from suppression of emotions, memories, and thoughts with integrated recorded operating system software, sold as a unit; Portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the deviceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 20, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 20, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 20, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Apr 20, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 20, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 20, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 13, 2023MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 13, 2023MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Apr 13, 2023ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 27, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 27, 2022DOCKASSIGNED TO EXAMINER—
Dec 30, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 27, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance